Home » Healthcare » Pharmaceuticals » Anti-inflammatory Drugs Market

Anti-inflammatory Drugs Market By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids) By Application (Autoimmune Inflammatory Diseases, Respiratory Diseases, Others) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

The global market for anti-inflammatory drugs is divided into drug class, application, method of administration, distribution channel, and region. Anti-inflammatory drugs are the most commonly used in autoimmune inflammatory illnesses, with oral and injectable being the two basic routes of administration. Furthermore, corticosteroids account for a significant share of the anti-inflammatory medications sector, the online pharmacy industry is expanding in popularity due to the convenience and accessibility it provides to patients in need of anti-inflammatory drugs, and North America has emerged as the largest market.

The frequency of inflammation-related disorders, as well as prospective pipeline candidates, is driving the worldwide anti-inflammatory medications market. However, the market confronts considerable obstacles, including the increased popularity of NSAID side effects, severe regulatory requirements, and generic competition.

Nonetheless, the global anti-inflammatory drugs market has considerable development prospects, including Biotechnology Advances and the release of novel anti-inflammatory medications. Furthermore, while the Asia-Pacific region is expected to see the most growth in the coming years, North America now has the greatest market for anti-inflammatory drugs.

Market Overview

The global anti-inflammatory drugs market has grown steadily in recent years and is predicted to increase at a 9.80% CAGR between 2023 and 2030. In 2022, the market was valued at USD 100.9 billion, and it is predicted to grow to USD 194.1 billion by 2030.

What Are the Primary Forces Driving the Global Anti-Inflammatory Drugs Market?

The worldwide anti-inflammatory pharmaceuticals market is being pushed by numerous factors, including the increasing frequency of inflammatory diseases and prospective pipeline candidates.

What Are the Global Anti-Inflammatory Drugs Market’s Major Challenges?

The global anti-inflammatory drugs market also faces several challenges, including patent expiration and the emergence of alternative medicines.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What Are the Opportunities for Growth in the Global Anti-Inflammatory Drugs Market?

The worldwide anti-inflammatory pharmaceuticals market provides considerable potential opportunities, including Biotechnology Advances and the introduction of novel anti-inflammatory medications.

Executive Summary

Overview of the Global Anti-Inflammatory Drugs Market

The anti-inflammatory drugs market is the pharmaceutical industry segment that focuses on the development, production, and sale of drugs used to reduce inflammation in the body. Inflammation is the immune system’s natural response to damage or infection, but persistent inflammation can lead to a variety of health problems such as arthritis, asthma, and inflammatory bowel disease. Anti-inflammatory medications are intended to lower inflammation and alleviate symptoms associated with certain illnesses. The anti-inflammatory medicine industry, which includes both prescription and over-the-counter treatments, is being pushed by reasons such as the increased prevalence of chronic inflammatory illnesses, the growing geriatric population, and rising demand for biologic drugs.

Market Definition

Anti-inflammatory drugs are used to treat acute & chronic disorders having an inflammatory aetiology. Therapeutic delivery of anti-inflammatory medications to the site of action while avoiding unwanted side effects. Anti-inflammatory drugs help to enhance the quality of life and management of a variety of rheumatic illnesses, including arthritis. Anti-inflammatory medications, particularly non-steroidal versions, play an important role in medical practise.

Market Insights

Anti-inflammatory drugs demand was estimated at USD 100.9 billion in 2022 and is predicted to reach USD 1194.1 billion in 2030, expanding at a CAGR of 9.80% between 2023 and 2030.
Nonsteroidal anti-inflammatory drugs (NSAIDs) led the market in 2022, accounting for 68% of the total.
The autoimmune inflammatory diseases category is predicted to develop at the fastest CAGR of 9.24%.
In 2022, the oral segment led the market with a market share of roughly 56%.
With a market share of roughly 54% in 2022, the retail pharmacies segment dominated the industry.
With a market share of roughly 39.88%, North America emerged as the largest market for worldwide anti-inflammatory drugs.
Asia Pacific is predicted to be the largest market throughout the forecast period.
The prevalence of inflammation-related illnesses and potential pipeline candidates is rising are the major drivers of the market.
At the same time, Side effects of NSAIDs, stringent regulatory requirements, and generic competition are the main restraints.
Biotechnology The primary an opportunity in the industry include advances and novel anti-inflammatory medications that are being introduced..

Segmentation by Drug Class

Nonsteroidal anti-inflammatory drugs (NSAIDs) led the market in 2022, accounting for 68% of the total.
Corticosteroids account for a sizable portion of the anti-inflammatory drugs industry.
Anti-inflammatory biologicsis another segment but contributes very little to the global anti-inflammatory drugs market compared to the Nonsteroidal anti-inflammatory drugs (NSAIDs) and Corticosteroids segments.

Segmentation by Application

The autoimmune inflammatory diseases category is predicted to develop at the fastest CAGR of 9.24%.
The respiratory diseases segment contributes the rest to the demand for anti-inflammatory drugs.

Segmentation by Route Of Administration

In 2022, the oral segment led the market with a market share of roughly 56%.
In the anti-inflammatory drugs market, the injection sector has the highest CAGR.
The market for anti-inflammatory drugs is expanding quickly in the inhalation category as respiratory disorders are becoming more common.

Segmentation by Distribution Channel

With a market share of roughly 54% in 2022, the retail pharmacies segment dominated the industry.
Anti-inflammatory drugs are in great demand in the hospital pharmacy sector in 2022.
The online pharmacy industry is growing in popularity due to the ease and accessibility it provides to patients in need of anti-inflammatory drugs.

Segmentation by Region

With a market share of roughly 39.88%, North America emerged as the largest market for worldwide anti-inflammatory drugs.
Asia Pacific is predicted to be the largest market throughout the forecast period.
The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for anti-inflammatory drugss.

The increasing demand for anti-inflammatory drugss can be attributed to the prevalence of inflammation-related illnesses and potential pipeline candidates are rising. However, the market is restrained by Side effects of NSAIDs, stringent regulatory requirements, and generic competition.

In terms of revenue, North America led the entire market in 2021, followed by Europe. Some of the primary reasons driving the industry’s growth are the existence of a large number of manufacturers and strategic initiatives implemented by market participants. Furthermore, the rising prevalence of chronic pain and arthritis is expected to drive growth during the forecast period.

During the projection period, Asia-Pacific is expected to be the fastest-growing region. The region’s growth is ascribed to causes such as an ageing population, an increase in the prevalence of chronic pain, migraines, and headaches, as well as an increase in product approvals and launches in the region.

Overall, the rising prevalence of inflammation-related disorders is driving up demand for anti-inflammatory medications, and the number of possible pipeline candidates is growing.

While the market for anti-inflammatory pharmaceuticals is expanding, it is being challenged by patent expiration and the emergence of alternative therapies.

Potential Candidates for the Pipeline

Increasing research efforts in biologics development for the treatment of autoimmune inflammatory illnesses have resulted in prospective pipeline medications. The benefits of monoclonal antibodies’ anti-inflammatory characteristics have turned the emphasis of pharmaceutical behemoths to this field. Anti-tumor necrosis factor (TF) inhibitors, interleukins, and other agents are being developed by the firms to treat a wide range of inflammatory illnesses. For example, UCB S.A. published excellent results from a phase 3 clinical research of Bimekizumab for the treatment of psoriasis in December 2019. Aside from that, the anti-inflammatory medicines market is expected to be driven by research & development of NSAIDs and corticosteroids for treating atopic dermatitis, plaque psoriasis, acute pain, and others over the forecast period.

Inflammatory diseases are becoming more prevalent.

One of the major factors driving the growth of the anti-inflammatory therapies market is the increasing prevalence of inflammatory illnesses such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, ulcerative colitis, and others. The Centres for Disease Control and Prevention estimates that 78 million adults in the United States will have doctor-diagnosed arthritis by 2040. During the projected period, this is expected to fuel the market. Furthermore, the increasing use of corticosteroids for the treatment of asthma and chronic obstructive pulmonary disease (COPD), as well as the rising prevalence of atopic dermatitis, are likely to drive market growth.

NSAID Side Effects

Non-Steroid Adverse Reactions Anti-inflammatory medications (NSAIDs) are likely to limit market growth due to side effects such as stomach ulcers, allergic reactions, disorientation, stomach pain, and others. Because they are effective anti-inflammatory medicines, NSAIDs are among the most often given medications. However, NSAID-related gastrointestinal problems have the potential to place a strain on the healthcare system. The most prevalent reason for hospitalisation is gastrointestinal bleeding. Gl problems caused by NSAIDs have become the most common adverse effect in the United States. This is projected to reduce market revenue in the next years.

Extensive Regulatory Requirements

The anti-inflammatory drug market is governed by severe regulatory standards, which can limit market expansion and have an impact on drug development. Before authorising new pharmaceuticals, regulatory bodies such as the FDA and EMA demand comprehensive clinical trials and safety data, which can be time-consuming and costly. The regulatory licencing procedure can also be complicated and difficult to navigate, especially for small businesses with limited resources. This may impede small companies’ capacity to enter the market and compete with larger, more established players.

Furthermore, regulatory agencies are increasingly focused on anti-inflammatory drug safety and efficacy, which can raise the cost and time required to bring new treatments to market. To address these issues, pharmaceutical companies are investing in innovative technology and drug development methodologies that can assist streamline the regulatory approval process and cut costs. These initiatives, however, may take time to bear fruit, and the regulatory landscape is likely to remain difficult for the foreseeable future.

Generic Competition

The market for anti-inflammatory medications is highly competitive, with many generic drugs accessible at cheaper prices than branded drugs. This may impede market expansion and have an influence on branded drug sales. Generic medications are often less expensive than branded drugs since they do not necessitate the same amount of R&D expenditure and can be made and sold by various producers. As a result, in order to save money, many patients and healthcare professionals prefer generic medications over branded drugs. This can reduce the market share and profitability of branded pharmaceuticals. To solve this issue, pharmaceutical companies are investing in innovative medication delivery technologies and formulations that have higher efficacy and fewer adverse effects than present treatments. However, these efforts can be costly and time-consuming, and they may not be sufficient to overcome generic competition.

Innovative Anti-Inflammatory Drugs Are Being Introduced

The launch of novel anti-inflammatory drugs is a prominent trend that is positively impacting the growth of the global anti-inflammatory therapeutics market. Cytokines are proteins produced by immune cells. These protein molecules allow cells to communicate with one another and are required for cell proliferation and differentiation, as well as immune system modulation. Small molecules that inhibit JAK have been developed in recent years, and many are currently undergoing clinical trials. XELJANZ (tofacitinib) has been approved by the US Food and Drug Administration as the first small-molecule JAK pathway inhibitor for the treatment of moderately to severely active RA.

Biotechnology Advances

The market for anti-inflammatory medications is shifting towards biologic drugs, which are produced from live cells and have various advantages over traditional small-molecule drugs. Biologics are extremely targeted and target the root causes of inflammation, resulting in better efficacy and fewer adverse effects. Furthermore, biologics have longer patent lifetimes than standard pharmaceuticals, which can assist producers in maintaining profitability and market position. Biosimilars, which are similar but not identical to existing biologics, are also boosting market expansion by offering patients with more economical options. To capitalise on these prospects, pharmaceutical companies are investing in R&D to develop new biologics and biosimilars that potentially enhance patient outcomes while lowering prices.

In order to fulfil the increased demand for these treatments, they are also expanding their manufacturing capacities. Overall, biologics breakthroughs give a substantial opportunity for the anti-inflammatory medicine market to grow and evolve in the next years.

Competitive Landscape

Key Players

The global anti-inflammatory drugs market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

AbbVie Inc.
Merck & Co., Inc.
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Pfizer Inc.
Novartis AG
GlaxoSmithKline plc.
Eli Lilly and Company
Amgen Inc.
Biogen
Others

These companies focus on product innovation, expanding their distribution channels, and mergers and acquisitions to stay ahead in the market.

The major players in the global anti-inflammatory drugs market are constantly striving to stay ahead by introducing new products and innovations.

Strides Pharma stated on August 2022, that the US Food and Drug Administration (USDA) had approved its Naproxen Sodium Softgel Capsules. Naproxen sodium softgel capsules are a nonsteroidal anti-inflammatory medication used to treat pain or inflammation caused by conditions such as arthritis, ankylosing spondylitis, tendinitis, bursitis, gout, or menstrual cramps. It can also be used to relieve acute pain caused by other illnesses. The US OTC market for Naproxen Sodium Softgel Capsules is estimated to be worth USD 100 million.

HUMIRA (adalimumab), according to a February 2021 release from AbbVie, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderately to very active ulcerative colitis in individuals 5 years of age and older.

Pfizer Inc. reports that the FDA approved tofacitinib, the substance that makes up XELJANZ XR, for the once-daily treatment of adult patients with moderately to severely active arthritis in October 2020.

Summary of Key Findings

The prevalence of inflammation-related illnesses and potential pipeline candidates is rising is driving market growth
Market segmented by drug class, application, route of administration, distribution channel, and region.
In 2022, the oral segment led the market with a market share of roughly 56%.
With a market share of roughly 54% in 2022, the retail pharmacies segment dominated the industry.
With a market share of roughly 39.88%, North America emerged as the largest market for worldwide anti-inflammatory drugs..

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Future Outlook

In the upcoming years, it is anticipated that the global market for anti-inflammatory medications would expand dramatically.
The market is being pushed by factors such the rising prevalence of chronic diseases, the growing elderly population, and the rising cost of healthcare.
The development of novel and cutting-edge anti-inflammatory medications, such as biologics and biosimilars, is also driving the market.
Although the Asia-Pacific area is anticipated to experience the biggest growth in the coming years, North America is currently the region with the largest market for anti-inflammatory medications.
Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline are a few of the market’s major participants.

Segmentation

By Drug Class
Anti-inflammatory Biologics
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
By Application
Autoimmune Inflammatory Diseases
Respiratory Diseases
Others
By Route of Administration
Oral
Injection
Topical
Inhalation
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – DataModelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Anti-Inflammatory Drugs Market
2.2. Global Anti-Inflammatory Drugs Market, By Drug Class
2.3. Global Anti-Inflammatory Drugs Market, By Application
2.4. Global Anti-Inflammatory Drugs Market, By Route of Administration
2.5. Global Anti-Inflammatory Drugs Market, By Distribution Channel
2.6. Global Anti-Inflammatory Drugs Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Anti-Inflammatory Drugs Market Value, 2017-2030, (US$ Billions)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Drug Class
3.5.2. Application
3.5.3. Route of Administration
3.5.4. Distribution Channel
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Drug Class Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Drug Class Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Anti-Inflammatory Drugs Market, By Drug Class
7.1. Global Anti-Inflammatory Drugs Market Overview, By Drug Class
7.1.1. Global Anti-Inflammatory Drugs Market Revenue Share, By Drug Class, 2022 Vs 2030 (in %)
7.2. Anti-inflammatory Biologics
7.2.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
7.3. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7.3.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
7.4. Corticosteroids
7.4.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)

8. Global Anti-Inflammatory Drugs Market, By Application
8.1. Global Anti-Inflammatory Drugs Market Overview, By Application
8.1.1. Global Anti-Inflammatory Drugs Market, By Application, 2022 vs. 2030 (in%)
8.2. Autoimmune Inflammatory Diseases
8.2.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
8.3. Respiratory Diseases
8.3.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
8.4. Others
8.4.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
8. Global Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030(US$ Billions)
8.7. Global Anti-Inflammatory Drugs Market Overview, By Route of Administration
8.7.1. Global Anti-Inflammatory Drugs Market, By Route of Administration, 2022 vs 2030 (in%)
8.8. Oral
8.8.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
8.9. Injection
8.9.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
8.10. Tropical
8.10.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
8.11. Inhalation
8.11.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)

9. Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030(US$ Billions)
10.1 Global Anti-Inflammatory Drugs Market Overview, By Distribution Channel
9.7.1. Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2022 vs 2030 (in %)
9.8. Hospital Pharmacy
9.8.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
9.9. Retail Pharmacy
9.9.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)
9.10. Online Pharmacy
9.10.1. Global Anti-Inflammatory Drugs Market, By Region, 2017-2030 (US$ Billions)

10. Global Anti-Inflammatory Drugs Market, By Region
10.7. Global Anti-Inflammatory Drugs Market Overview, by Region
10.7.1. Global Anti-Inflammatory Drugs Market, By Region, 2022 vs 2030 (in%)
10.8. Drug Class
10.8.1. Global Anti-Inflammatory Drugs Market, By Drug Class, 2017-2030 (US$ Billions)
10.9. Application
10.9.1. Global Anti-Inflammatory Drugs Market, By Application, 2017-2030 (US$ Billions)
10.10. Route of Administration
10.10.1. Global Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030 (US$ Billions)
10.11. Distribution Channel
10.11.1. Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030 (US$ Billions)

11. North America Anti-Inflammatory Drugs Market Analysis
11.7. North America Anti-Inflammatory Drugs Market, By Drug Class, 2017-2030(US$ Billions)
11.7.1. Overview
11.7.2. SRC Analysis
11.8. North America Anti-Inflammatory Drugs Market, By Application, 2017-2030(US$ Billions)
11.8.1. Overview
11.8.2. SRC Analysis
11.9. North America Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030(US$ Billions)
11.9.1. Overview
11.9.2. SRC Analysis
11.10. North America Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030(US$ Billions)
11.10.1. Overview
11.10.2. SRC Analysis
11.11. North America Anti-Inflammatory Drugs Market, by Country, 2017-2030(US$ Billions)
11.11.1. North America Anti-Inflammatory Drugs Market, by Country, 2022 Vs 2030 (in %)
11.11.2. U.S.
11.11.2.1. U.S. Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
11.11.2.2. U.S. Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
11.11.2.3. U.S. Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
11.11.2.4. U.S. Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
11.11.2.5. U.S. Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
11.11.3. Canada
11.11.3.1. Canada Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
11.11.3.2. Canada Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
11.11.3.3. Canada Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
11.11.3.4. Canada Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
11.11.3.5. Canada Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
11.11.4. Mexico
11.11.4.1. Mexico Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030 (US$ Billions)
11.11.4.2. Mexico Anti-Inflammatory Drugs, By Drug Class, 2017-2030 (US$ Billions)
11.11.4.3. Mexico Anti-Inflammatory Drugs, By Application, 2017-2030 (US$ Billions)
11.11.4.4. Mexico Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
11.11.4.5. Mexico Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)

12. Europe Anti-Inflammatory Drugs Market Analysis
12.7. Europe Anti-Inflammatory Drugs Market, By Drug Class, 2017-2030(US$ Billions)
12.7.1. Overview
12.7.2. SRC Analysis
12.8. Europe Anti-Inflammatory Drugs Market, By Application, 2017-2030(US$ Billions)
12.8.1. Overview
12.8.2. SRC Analysis
12.9. Europe Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030(US$ Billions)
12.9.1. Overview
12.9.2. SRC Analysis
12.10. Europe Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030(US$ Billions)
12.10.1. Overview
12.10.2. SRC Analysis
12.11. Europe Anti-Inflammatory Drugs Market, by Country, 2017-2030(US$ Billions)
12.11.1. EuropeAnti-Inflammatory Drugs Market, by Country, 2022 Vs 2030 (in%)
12.11.2. Germany
12.11.2.1. Germany Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
12.11.2.2. Germany Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
12.11.2.3. Germany Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
12.11.3. Germany Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
12.11.4. Germany Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
12.11.5. France
12.11.5.1. France Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
12.11.5.2. France Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
12.11.5.3. France Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
12.11.5.4. France Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
12.11.5.5. France Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
12.11.6. UK
12.11.6.1. UK Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
12.11.6.2. UK Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
12.11.6.3. UK Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
12.11.6.4. UK Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
12.11.6.5. UK Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
12.11.7. Italy
12.11.7.1. Italy Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
12.11.7.2. Italy Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
12.11.7.3. Italy Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
12.11.7.4. Italy Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
12.11.7.5. Italy Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
12.11.8. Spain
12.11.8.1. Spain Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
12.11.8.2. Spain Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
12.11.8.3. Spain Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
12.11.8.4. Spain Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
12.11.8.5. Spain Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
12.11.9. Rest of Europe
12.11.9.1. Rest of Europe Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
12.11.9.2. Rest of Europe Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
12.11.9.3. Rest of Europe Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
12.11.9.4. Rest of Europe Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
12.11.9.5. Rest of Europe Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)

13. Asia Pacific Anti-Inflammatory Drugs Market Analysis
13.7. Asia Pacific Anti-Inflammatory Drugs Market, By Drug Class, 2017-2030(US$ Billions)
13.7.1. Overview
13.7.2. SRC Analysis
13.8. Asia Pacific Anti-Inflammatory Drugs Market, By Application, 2017-2030(US$ Billions)
13.8.1. Overview
13.8.2. SRC Analysis
13.9. Asia Pacific Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030(US$ Billions)
13.9.1. Overview
13.9.2. SRC Analysis
13.10. Asia Pacific Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030(US$ Billions)
13.10.1. Overview
13.10.2. SRC Analysis
13.11. Asia Pacific Anti-Inflammatory Drugs Market, by Country, 2017-2030(US$ Billions)
13.11.1. Asia PacificAnti-Inflammatory Drugs Market, by Country, 2022 Vs 2030 (in%)
13.11.2. China
13.11.2.1. China Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
13.11.2.2. China Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
13.11.2.3. China Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
13.11.2.4. China Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
13.11.2.5. China Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
13.11.3. Japan
13.11.3.1. Japan Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
13.11.3.2. Japan Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
13.11.3.3. Japan Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
13.11.3.4. Japan Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
13.11.3.5. Japan Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
13.11.4. India
13.11.4.1. India Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
13.11.4.2. India Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
13.11.4.3. India Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
13.11.4.4. India Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
13.11.4.5. India Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
13.11.5. South Korea
13.11.5.1. South Korea Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
13.11.5.2. South Korea Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
13.11.5.3. South Korea Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
13.11.5.4. South Korea Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
13.11.5.5. South Korea Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
13.11.6. South-East Asia
13.11.6.1. South-East Asia Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
13.11.6.2. South-East Asia Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
13.11.6.3. South-East Asia Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
13.11.6.4. South-East Asia Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
13.11.6.5. South-East Asia Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
13.11.7. Rest of Asia Pacific
13.11.7.1. Rest of Asia Pacific Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
13.11.7.2. Rest of Asia Pacific Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
13.11.7.3. Rest of Asia Pacific Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
13.11.7.4. Rest of Asia Pacific Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
13.11.7.5. Rest of Asia Pacific Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)

14. Latin America Anti-Inflammatory Drugs Market Analysis
14.7. Latin America Anti-Inflammatory Drugs Market, By Drug Class, 2017-2030(US$ Billions)
14.7.1. Overview
14.7.2. SRC Analysis
14.8. Latin America Anti-Inflammatory Drugs Market, By Application, 2017-2030(US$ Billions)
14.8.1. Overview
14.8.2. SRC Analysis
14.9. Latin America Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030(US$ Billions)
14.9.1. Overview
14.9.2. SRC Analysis
14.10. Latin America Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030(US$ Billions)
14.10.1. Overview
14.10.2. SRC Analysis
14.11. Latin America Anti-Inflammatory Drugs Market, by Country, 2017-2030(US$ Billions)
14.11.1. LatinAmerica Anti-Inflammatory Drugs Market, by Country, 2022 Vs 2030 (in%)
14.11.2. Brazil
14.11.2.1. Brazil Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
14.11.2.2. Brazil Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
14.11.2.3. Brazil Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
14.11.2.4. Brazil Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
14.11.2.5. Brazil Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
14.11.3. Argentina
14.11.3.1. Argentina Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
14.11.3.2. Argentina Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
14.11.3.3. Argentina Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
14.11.3.4. Argentina Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
14.11.3.5. Argentina Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
14.11.4. Rest of Latin America
14.11.4.1. Rest of Latin America Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
14.11.4.2. Rest of Latin America Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
14.11.4.3. Rest of Latin America Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
14.11.4.4. Rest of Latin America Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
14.11.4.5. Rest of Latin America Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)

15. Middle East and Africa Anti-Inflammatory Drugs Market Analysis
15.7. Middle East and Africa Anti-Inflammatory Drugs Market, By Drug Class, 2017-2030(US$ Billions)
15.7.1. Overview
15.7.2. SRC Analysis
15.8. Middle East and Africa Anti-Inflammatory Drugs Market, By Application, 2017-2030(US$ Billions)
15.8.1. Overview
15.8.2. SRC Analysis
15.9. Middle East and Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2030(US$ Billions)
15.9.1. Overview
15.9.2. SRC Analysis
15.10. Middle East and Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2030(US$ Billions)
15.10.1. Overview
15.10.2. SRC Analysis
15.11. Middle East and Africa Anti-Inflammatory Drugs Market, by Country, 2017-2030(US$ Billions)
15.11.1. Middle East and AfricaAnti-Inflammatory Drugs Market, by Country, 2022 Vs 2030 (in%)
15.11.2. GCC Countries
15.11.2.1. GCC Countries Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
15.11.2.2. GCC Countries Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
15.11.2.3. GCC Countries Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
15.11.2.4. GCC Countries Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
15.11.2.5. GCC Countries Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
15.11.3. South Africa
15.11.3.1. South Africa Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
15.11.3.2. South Africa Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
15.11.3.3. South Africa Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
15.11.3.4. South Africa Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
15.11.3.5. South Africa Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)
15.11.4. Rest of Middle East and Africa
15.11.4.1. Rest of Middle East and Africa Anti-Inflammatory Drugs Market Estimates and Forecast, 2017-2030(US$ Billions)
15.11.4.2. Rest of Middle East and Africa Anti-Inflammatory Drugs, By Drug Class, 2017-2030(US$ Billions)
15.11.4.3. Rest of Middle East and Africa Anti-Inflammatory Drugs, By Application, 2017-2030(US$ Billions)
15.11.4.4. Rest of Middle East and Africa Anti-Inflammatory Drugs, By Route of Administration, 2017-2030 (US$ Billions)
15.11.4.5. Rest of Middle East and Africa Anti-Inflammatory Drugs, By Distribution Channel, 2017-2030 (US$ Billions)

16. Company Profiles
16.7. AbbVie Inc.
16.7.1. Company Overview
16.7.2. Drug Classs/Services Portfolio
16.7.3. Geographical Presence
16.7.4. Financial Summary
16.7.4.1. Market Revenue and Net Profit (2019-2022)
16.7.4.2. Business Segment Revenue Analysis
16.7.4.3. Geographical Revenue Analysis
16.8. Merck & Co., Inc.
16.9. Bristol-Myers Squibb Company
16.10. Johnson & Johnson Services, Inc.
16.11. Pfizer Inc.
16.12. Novartis AG
16.13. GlaxoSmithKline plc.
16.14. Eli Lilly and Company
16.15. Amgen Inc.
16.16. Biogen

List of Figures
FIG. 1 Global Anti-Inflammatory Drugs Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Anti-Inflammatory Drugs Market Segmentation
FIG. 4 Global Anti-Inflammatory Drugs Market, By Drug Class, 2022(US$ Billions)
FIG. 5 Global Anti-Inflammatory Drugs Market, By Application, 2022(US$ Billions)
FIG. 6 Global Anti-Inflammatory Drugs Market, By Route of Administration, 2022 (US$ Billions)
FIG. 7 Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2022 (US$ Billions)
FIG. 8 Global Anti-Inflammatory Drugs Market, by Geography, 2022(US$ Billions)
FIG. 9 Attractive Investment Proposition, By Drug Class, 2022
FIG. 10 Attractive Investment Proposition, By Application, 2022
FIG. 11 Attractive Investment Proposition, By Route of Administration, 2022
FIG. 12 Attractive Investment Proposition, By Distribution Channel, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Anti-Inflammatory Drugs Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Anti-Inflammatory Drugs Market Manufacturers, 2022
FIG. 16 Global Anti-Inflammatory Drugs Market Value Contribution, By Drug Class, 2022&2030 (Value %)
FIG. 17 Global Anti-Inflammatory DrugsMarket, by Anti-inflammatory Biologics, Value, 2017-2030(US$ Billions)
FIG. 18 Global Anti-Inflammatory DrugsMarket, by Non-steroidal Anti-inflammatory Drugs (NSAIDs), Value, 2017-2030(US$ Billions)
FIG. 19 Global Anti-Inflammatory DrugsMarket, by Corticosteroids, Value, 2017-2030(US$ Billions)
FIG. 20 Global Anti-Inflammatory Drugs Market Value Contribution, By Application, 2022&2030 (Value %)
FIG. 21 Global Anti-Inflammatory DrugsMarket, by Autoimmune Inflammatory Diseases, Value, 2017-2030(US$ Billions)
FIG. 22 Global Anti-Inflammatory DrugsMarket, by Respiratory Diseases, 2017-2030(US$ Billions)
FIG. 23 Global Anti-Inflammatory Drugs Market, by Others, 2017-2030(US$ Billions)
FIG. 24 Global Anti-Inflammatory Drugs Market Value Contribution, By Route of Administration, 2022 & 2030 (Value %)
FIG. 25 Global Anti-Inflammatory Drugs Market, by Oral, Value, 2017-2030 (US$ Billions)
FIG. 26 Global Anti-Inflammatory Drugs Market, by Injection, 2017-2030 (US$ Billions)
FIG. 27 Global Anti-Inflammatory Drugs Market, by Topical, 2017-2030 (US$ Billions)
FIG. 28 Global Anti-Inflammatory Drugs Market, by Inhalation, 2017-2030 (US$ Billions)
FIG. 29 Global Anti-Inflammatory Drugs Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 30 Global Anti-Inflammatory Drugs Market, by Hospital Pharmacy, Value, 2017-2030 (US$ Billions)
FIG. 31 Global Anti-Inflammatory Drugs Market, by Retail Pharmacy, Value, 2017-2030 (US$ Billions)
FIG. 32 Global Anti-Inflammatory Drugs Market, by Online Pharmacy, Value, 2017-2030 (US$ Billions)
FIG. 33 North America Anti-Inflammatory Drugs Market, 2017-2030 (US$ Billions)
FIG. 34 U.S. Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 35 Canada Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 36 Europe Anti-Inflammatory Drugs Market, 2017-2030 (US$ Billions)
FIG. 37 Germany Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 38 France Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 39 U.K. Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 40 Italy Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 41 Spain Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 42 Rest of Europe Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 43 Asia Pacific Anti-Inflammatory Drugs Market, 2017-2030 (US$ Billions)
FIG. 44 China Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 45 Japan Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 46 India Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 47 South Korea Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 48 South-East Asia Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 49 Rest of Asia Pacific Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 50 Latin America Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 51 Brazil Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 52 Mexico Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 53 Rest of Latin America Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 54 Middle East & Africa Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 55 GCC Countries Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 56 South Africa Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)
FIG. 57 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, 2017-2030(US$ Billions)

List of Tables
TABLE 1 Market Snapshot: Global Anti-Inflammatory DrugsMarket
TABLE 2 Global Anti-Inflammatory Drugs Market: Market Drivers Impact Analysis
TABLE 3 Global Anti-Inflammatory Drugs Market: Market Restraints Impact Analysis
TABLE 4 Global Anti-Inflammatory Drugs Market, by Competitive Benchmarking,2022
TABLE 5 Global Anti-Inflammatory Drugs Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Anti-Inflammatory Drugs Market, by Key Strategies Analysis, 2022
TABLE 7 Global Anti-Inflammatory Drugs Market, by Anti-inflammatory Biologics, By Region, 2017-2022(US$ Billions)
TABLE 8 Global Anti-Inflammatory Drugs Market, by Anti-inflammatory Biologics, By Region, 2023-2030 (US$ Billions)
TABLE 9 Global Anti-Inflammatory Drugs Market, by Non-steroidal Anti-inflammatory Drugs (NSAIDs), By Region, 2017-2022 (US$ Billions)
TABLE 10 Global Anti-Inflammatory Drugs Market, by Non-steroidal Anti-inflammatory Drugs (NSAIDs), By Region, 2023-2030(US$ Billions)
TABLE 11 Global Anti-Inflammatory Drugs Market, by Corticosteroids, By Region, 2017-2022 (US$ Billions)
TABLE 12 Global Anti-Inflammatory Drugs Market, by Corticosteroids, By Region, 2023-2030(US$ Billions)
TABLE 13 Global Anti-Inflammatory Drugs Market, by Autoimmune Inflammatory Diseases, By Region, 2017-2022(US$ Billions)
TABLE 14 Global Anti-Inflammatory Drugs Market, by Autoimmune Inflammatory Diseases, By Region, 2023-2030(US$ Billions)
TABLE 15 Global Anti-Inflammatory Drugs Market, by Respiratory Diseases, By Region, 2017-2022(US$ Billions)
TABLE 16 Global Anti-Inflammatory Drugs Market, by Respiratory Diseases, By Region, 2023-2030(US$ Billions)
TABLE 17 Global Anti-Inflammatory Drugs Market, by Others, By Region, 2017-2022(US$ Billions)
TABLE 18 Global Anti-Inflammatory Drugs Market, by Others, By Region, 2023-2030(US$ Billions)
TABLE 19 Global Anti-Inflammatory Drugs Market, by Oral, By Region, 2017-2022(US$ Billions)
TABLE 20 Global Anti-Inflammatory Drugs Market, by Oral, By Region, 2023-2030(US$ Billions)
TABLE 21 Global Anti-Inflammatory Drugs Market, by Injection, By Region, 2017-2022(US$ Billions)
TABLE 22 Global Anti-Inflammatory Drugs Market, by Injection, By Region, 2023-2030(US$ Billions)
TABLE 23 Global Anti-Inflammatory Drugs Market, by Topical, By Region, 2017-2022(US$ Billions)
TABLE 24 Global Anti-Inflammatory Drugs Market, by Topical, By Region, 2023-2030(US$ Billions)
TABLE 25 Global Anti-Inflammatory Drugs Market, by Inhalation, By Region, 2017-2022(US$ Billions)
TABLE 26 Global Anti-Inflammatory Drugs Market, by Inhalation, By Region, 2023-2030(US$ Billions)
TABLE 27 Global Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 28 Global Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 29 Global Anti-Inflammatory Drugs Market, By Application, 2017-2022(US$ Billions)
TABLE 30 Global Anti-Inflammatory Drugs Market, By Application, 2023-2030(US$ Billions)
TABLE 31 Global Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 32 Global Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030 (US$ Billions)
TABLE 33 Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 34 Global Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 35 Global Anti-Inflammatory Drugs Market, by Region, 2017-2022(US$ Billions)
TABLE 36 Global Anti-Inflammatory Drugs Market, by Region, 2023-2030(US$ Billions)
TABLE 37 North America Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 38 North America Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 39 North America Anti-Inflammatory Drugs Market, By Application, 2017-2022(US$ Billions)
TABLE 40 North America Anti-Inflammatory Drugs Market, By Application, 2023-2030(US$ Billions)
TABLE 41 North America Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 42 North America Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 43 North America Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 44 North America Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 45 North America Anti-Inflammatory Drugs Market, by Country, 2017-2022(US$ Billions)
TABLE 46 North America Anti-Inflammatory Drugs Market, by Country, 2023-2030(US$ Billions)
TABLE 47 United States Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 48 United States Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 49 United States Anti-Inflammatory Drugs Market, By Application, 2017-2022(US$ Billions)
TABLE 50 United States Anti-Inflammatory Drugs Market, By Application, 2023-2030(US$ Billions)
TABLE 51 United States Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 52 United States Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 53 United States Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 54 United States Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 55 Canada Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 56 Canada Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 57 Canada Anti-Inflammatory Drugs Market, by Applications, 2017-2022(US$ Billions)
TABLE 58 Canada Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 59 Canada Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 60 Canada Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 61 Canada Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 62 Canada Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 63 Mexico Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 64 Mexico Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 65 Mexico Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 66 Mexico Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 67 Mexico Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 68 Mexico Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 69 Mexico Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 70 Mexico Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 71 Europe Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 72 Europe Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 73 Europe Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 74 Europe Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 75 Europe Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 76 Europe Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 77 Europe Anti-Inflammatory Drugs Market, by Distribution Channel, 2017-2022(US$ Billions)
TABLE 78 Europe Anti-Inflammatory Drugs Market, by Distribution Channel, 2023-2030(US$ Billions)
TABLE 79 Germany Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 80 Germany Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 81 Germany Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 82 Germany Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 83 Germany Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 84 Germany Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 85 Germany Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 86 Germany Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 87 France Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 88 France Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 89 France Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 90 France Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 91 France Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 92 France Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 93 France Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 94 France Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 95 United Kingdom Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 96 United Kingdom Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 97 United Kingdom Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 98 United Kingdom Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 99 United Kingdom Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 100 United Kingdom Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 101 United Kingdom Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 102 United Kingdom Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 103 Italy Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 104 Italy Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 105 Italy Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 106 Italy Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 107 Italy Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 108 Italy Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 109 Italy Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 110 Italy Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 111 Spain Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 112 Spain Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 113 Spain Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 114 Spain Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 115 Spain Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 116 Spain Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 117 Spain Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 118 Spain Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 119 Rest of Europe Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 120 Rest of Europe Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 121 Rest of Europe Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 122 Rest of Europe Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 123 Rest of Europe Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 124 Rest of Europe Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 125 Rest of Europe Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 126 Rest of Europe Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 127
TABLE 128 Asia Pacific Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 129 Asia Pacific Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 130 Asia Pacific Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 131 Asia Pacific Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 132 Asia Pacific Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 133 Asia Pacific Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 134 Asia Pacific Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 135 Asia Pacific Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 136 China Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 137 China Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 138 China Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 139 China Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 140 China Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 141 China Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 142 China Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 143 China Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 144 Japan Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 145 Japan Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 146 Japan Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 147 Japan Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 148 Japan Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 149 Japan Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 150 Japan Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 151 Japan Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 152 India Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 153 India Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 154 India Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 155 India Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 156 India Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 157 India Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 158 India Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 159 India Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 160 South Korea Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 161 South Korea Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 162 South Korea Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 163 South Korea Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 164 South Korea Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 165 South Korea Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 166 South Korea Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 167 South Korea Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 168 South-East Asia Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 169 South-East Asia Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 170 South-East Asia Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 171 South-East Asia Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 172 South-East Asia Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 173 South-East Asia Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 174 South-East Asia Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 175 South-East Asia Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 176 Rest of Asia Pacific Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 177 Rest of Asia Pacific Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 178 Rest of Asia Pacific Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 179 Rest of Asia Pacific Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 180 Rest of Asia Pacific Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 181 Rest of Asia Pacific Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 182 Rest of Asia Pacific Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 183 Rest of Asia Pacific Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 184 Latin America Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 185 Latin America Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 186 Latin America Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 187 Latin America Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 188 Latin America Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 189 Latin America Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 190 Latin America Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 191 Latin America Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 192 Brazil Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 193 Brazil Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 194 Brazil Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 195 Brazil Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 196 Brazil Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 197 Brazil Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 198 Brazil Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 199 Brazil Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 200 Argentina Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 201 Argentina Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 202 Argentina Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 203 Argentina Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 204 Argentina Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 205 Argentina Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 206 Argentina Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 207 Argentina Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 208 Rest of Latin America Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 209 Rest of Latin America Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 210 Rest of Latin America Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 211 Rest of Latin America Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 212 Rest of Latin America Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 213 Rest of Latin America Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 214 Rest of Latin America Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 215 Rest of Latin America Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 216 Middle East and Africa Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 217 Middle East and Africa Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 218 Middle East and Africa Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 219 Middle East and Africa Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 220 Middle East and Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 221 Middle East and Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 222 Middle East and Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 223 Middle East and Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 224 GCC Countries Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 225 GCC Countries Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 226 GCC Countries Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 227 GCC Countries Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 228 GCC Countries Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 229 GCC Countries Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 230 GCC Countries Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 231 GCC Countries Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 232 South Africa Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 233 South Africa Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 234 South Africa Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 235 South Africa Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 236 South Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 237 South Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 238 South Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 239 South Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)
TABLE 240 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, By Drug Class, 2017-2022(US$ Billions)
TABLE 241 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, By Drug Class, 2023-2030(US$ Billions)
TABLE 242 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, by Application, 2017-2022(US$ Billions)
TABLE 243 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, by Application, 2023-2030(US$ Billions)
TABLE 244 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2017-2022(US$ Billions)
TABLE 245 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, By Route of Administration, 2023-2030(US$ Billions)
TABLE 246 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2017-2022(US$ Billions)
TABLE 247 Rest of Middle East and Africa Anti-Inflammatory Drugs Market, By Distribution Channel, 2023-2030(US$ Billions)

Frequently Asked Questions

How big is the worldwide anti-inflammatory drugs market right now?

In 2022, the global anti-inflammatory medicines market is expected to be worth USD 100.9 billion.

What is the predicted rate of growth in the anti-inflammatory drug industry between 2023 and 2030?

The market for anti-inflammatory drugs is estimated to increase at a 9.80% CAGR between 2023 and 2030, reaching USD 194.1 billion in 2030.

Which segment is leading the market share in terms of drug class?

Nonsteroidal anti-inflammatory drugs (NSAIDs) led the market in 2022, accounting for 68% of the total.

Which application segment governs the demand for anti-inflammatory drugss in the world?

The respiratory diseases segment contributes the rest to the demand for anti-inflammatory drugs.

Which segment is expected to post the highest CAGR during the forecast period?

In the anti-inflammatory drugs market, the injection sector has the highest CAGR.

Which region is fueling the growth of the anti-inflammatory drugs industry?

Asia Pacific is fueling the growth of the anti-inflammatory drugs industry, with over one-third share in 2022.

Who are the major players in the global anti-inflammatory drugs market?

Other important participants include Pfizer Inc., Novartis AG, GlaxoSmithKline plc, and Amgen Inc., as well as AbbVie Inc, Merck & Co., Inc, and Bristol-Myers Squibb Company.

What are the major market drivers of the anti-inflammatory drugs industry?

The prevalence of inflammation-related illnesses and potential pipeline candidates is raising are the major market drivers.

What are the major market restraints of the anti-inflammatory drugs industry?

Side effects of NSAIDs, stringent regulatory requirements, and generic competition are the major market restraints.

What are the major market opportunities of the anti-inflammatory drugs industry?

Biotechnology Advances and novel anti-inflammatory medications are being introduced are the major opportunities in the anti-inflammatory drugs industry.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –